Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomised Controlled Trial Evaluating the Safety and Efficacy of Antifibrinolytics (Tranexamic Acid) in Patients With Haematological Malignancies With Severe Thrombocytopenia

NCT03136445 is registered in ClinicalTrials.gov with NHS Blood and Transplant as lead sponsor.

NCT NCT03136445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03136445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomised Controlled Trial Evaluating the Safety and Efficacy of Antifibrinolytics (Tranexamic Acid) in Patients With Haematological Malignancies With Severe Thrombocytopenia
Lead sponsor
NHS Blood and Transplant
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2015
Completion date
June 18, 2022
Enrollment
616 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic neoplasms, hematopoietic stem cell transplantation, hemorrhage